Embryonic origin of preimplantation factor (PIF): biological activity and partial characterization.
Preimplantation factor (PIF) is detected in the serum of women shortly after fertilization; its origin, however, has not been established. In this study, the embryonal origin of PIF was investigated and partial characterization of the factor was carried out. Culture media from viable human 2-8-cell stage embryos and mouse 2-cell-blastocyst stage embryos were analysed using the lymphocyte/platelet binding assay (LPBA). The assay was performed by combining culture media with donor O+ type blood-derived lymphocytes/platelets, complement and an antibody against CD2. Increased autorosette formation between lymphocytes and platelets (> 9%) was an indication for the presence of PIF. In addition, the effect of platelet-activating factor (PAF) and chaperonin 10 on PIF activity was determined. Partial purification of PIF was carried out using gel filtration and reverse-phase high purification liquid chromatography (HPLC), followed by mass spectrometry. Culture media of single human viable fertilized oocytes were negative for PIF; however, the 10-fold concentrated medium was positive for PIF. In medium in which five or more mouse embryos were cultured, PIF activity was observed starting at the morula stage and was higher by the blastocyst stage. Addition of PAF or chaperonin 10 to the PIF assay did not elicit a specific effect on PIF activity. Chromatographic data suggest that PIF activity is due to low molecular weight proteins. PIF appears to be a low molecular weight protein which is derived from viable preimplantation embryos. It is different from PAF or chaperonin 10. Its final characterization will be valuable for better understanding of maternal recognition of pregnancy and implantation.
Roussev
R G
RG
Center for Human Reproduction, Chicago, IL, USA.
Coulam
C B
CB
Kaider
B D
BD
Yarkoni
M
M
Leavis
P C
PC
Barnea
E R
ER
D000818:Animals; D001685:Biological Factors / Q000097:blood* / Q000302:isolation & purification / Q000378:metabolism; D015415:Biomarkers / Q000097:blood; D001755:Blastocyst / Q000187:drug effects / Q000378:metabolism; D018835:Chaperonin 10 / Q000494:pharmacology; D002970:Cleavage Stage, Ovum / Q000187:drug effects / Q000378:metabolism; D004622:Embryo, Mammalian / Q000378:metabolism*; D047108:Embryonic Development / Q000502:physiology*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D009028:Morula / Q000187:drug effects / Q000378:metabolism; D010455:Peptides / Q000097:blood* / Q000302:isolation & purification / Q000378:metabolism; D010972:Platelet Activating Factor / Q000494:pharmacology; D011247:Pregnancy; D011258:Pregnancy Tests
D001685:Biological Factors; D015415:Biomarkers; D018835:Chaperonin 10; D010455:Peptides; D010972:Platelet Activating Factor; C561617:preimplantation factor, mouse